Stocks and Investing Stocks and Investing
Wed, August 19, 2020
Tue, August 18, 2020
Mon, August 17, 2020

Raghuram Selvaraju Maintained (BTAI) at Strong Buy with Decreased Target to $175 on, Aug 17th, 2020


Published on 2024-10-27 12:18:26 - WOPRAI, Raghuram Selvaraju
  Print publication without navigation


Raghuram Selvaraju of HC Wainwright & Co., Maintained "BioXcel Therapeutics, Inc." (BTAI) at Strong Buy with Decreased Target from $200 to $175 on, Aug 17th, 2020.

Raghuram has made no other calls on BTAI in the last 4 months.



There is 1 other peer that has a rating on BTAI. Out of the 1 peers that are also analyzing BTAI, 0 agree with Raghuram's Rating of Hold.



This is the rating of the analyst that currently disagrees with Raghuram


  • Geoff Meacham of "B of A Securities" Reiterated at Strong Buy with Increased Target to $63 on, Monday, July 13th, 2020
Contributing Sources